Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells

Life Sciences

Volumn 62, Issue 24, 1998, Pages 2195-2201

  Bryant, Clare E ^a   Appleton, Ian ^b   Mitchell, Jane A ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

COX 2; HUVEC3; Nitric oxide synthase; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; INDOMETACIN; MITOGENIC AGENT; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; VASCULOTROPIN;

ANIMAL CELL; AORTA; ARTICLE; CATTLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; NONHUMAN; UMBILICAL VEIN;

ANIMALS; BLOTTING, WESTERN; CATTLE; CELL DIVISION; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; INDOMETHACIN; ISOENZYMES; LYMPHOKINES; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0032496189     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00197-0     Document Type: Article

References (30)

1. 1. J. FOLKMAN. and Y. SHING. (1992) J. Biol. Chem., 267, 10931-10934
2. 2. D.W. LEUNG, G. CACHIANES, W.J. KUANG, D.V. GOEDDEL and N. FERRARA (1989) Science, 246, 1306-1309
3. 3. D.T. CONNOLLY, D.M. HEUVEL, R. NELSON, J.V. OLANDER, B.L. EPPLEY, J.J. DELFINO, N.R. SIEGAL, R.M. LEIMGRUBER and J. FEDER (1989) J. Clin. Invest., 84, 1470-1478
4. 4. I. APPLETON, N.J. BROWN, D. WILLIS, P.R. COLVILLE-NASH, C. ALAM, J.R. BROWN and D.A. WILLOUGHBY (1996) J. Pathol., 180, 90-94
5. 5. K.J. KIM, B. LI, J. WINER, M. ARMANINI, N. GILLET, H.S. PHILLIPS and N. FERRARA (1993) Nature, 362, 841-844
6. 6. J. WLATENBERGER, L. CLAESSONWELSH, A. SIEGBAHN, M. SHIBUYA and C.H. HELDIN (1994) J. Biol. Chem., 269, 26988-26995
7. 7. L. SEETHARAM, N. GOTOH, Y. MARU, G. NEUFELD, S. YAMAGUCHI and M. SHIBUYA (1995) Oncogene, 10, 135-147
8. 8. G. DANGELO, I. STRUMAN, J. MARTIAL, R.I. WEINER (1995) Proc. Natl. Acad. Sci., 92, 6374-6378
9. 9. M. ZICHE, L. MORBIDELLI, E. MASINI, S. AMRINI, H.J. GRANGER, C.A. MAGGI, P. GEPPETTI and F. LEDDA (1994) J. Clin. Invest., 94, 2036-2044
10. 10. E. SPISNI, F. MANICA and V. TOMASI (1992) Prostaglandins, Leukotrienes and Essential Fatty Acids, 47, 111-115
11. 11. J.S. POLLOCK, U. FÖSTERMANN, J.A. MITCHELL, T.D. WARNER, H.H.H.W. SCHMIDT, M. NAKANE and F. MURAD (1991) Proc. Natl. Acad. Sci., 88, 10480-10484.
12. 12. J.A. MITCHELL, P. AKARASEREENONT, C. THIEMERMANN, R.J. FLOWER and J.R. VANE (1993) Procedings of the National Acadamy of Science (USA), 90, 11693-11697
13. 13. S.S. GROSS, E.A. JAFFE, R. LEVI and R.G. KILBOURN(1991) Biochem. Biophys. Res. Commun., 178, 823-829
14. 14. T. HLA and K. NIELSON (1992) Proc. Natl. Acad. Sci., 89, 8384-8388
15. 15. L. MORBIDELLI, C.H. CHANG, J.G. DOUGLAS, H.J. GRANGER, F. LEDDA and M. ZICHE (1996) Am. J. Physiol., 39, H411-415
16. 16. J.A. MITCHELL, S. LARKIN and T.J. WILLAMS (1995) Biochem. Pharmacol., 50, 1535-1542
17. 17. N. FUTAKI, S. TAKAHASHI, M. YOKOYAMA, I. ARAI, S. HIGUCHI and S. OTOMO (1994) Prostaglandins, 47, 55-59
18. 18. C.E. BRYANT, A. TOMLINSON, J.A. MITCHELL, C. THIEMERMANN and D.A. WILLOUGHBY (1995) J. Endocrinol., 146, 149-157
19. 19. C.C. CHAN, S. BOYCE, C. BRIDEAU, A.W. FORD-HUTCHINSON, R. GORDON, D. GUAY, R.G. HILL, C.S. LI, J. MANCINI, M. PENNETON, P. PRASIT, R. RASORI, D. RIENDAU, P. ROY, P. TAGARI, P. VICKERS, E. WONG and I.W. ROGER (1995) J. Pharmacol. Expt. Ther., 274, 1531-1537
20. 20. M.M. BRADFORD (1976) Ann. Biochem., 72, 248-254
21. 21. P. AKARASEREENONT, J.A. MITCHELL, C. THIEMERMANN and J.R. VANE (1995) Eur. J. Pharmacol., 173, 121-128
22. 22. X.M. XU, J.L. TANG, A. HAJIBEIGI, D.S. LOOSEMITCHELL and K.K. WU (1996) Am. J. Physiol., C259-264
23. 23. P. TOTH, X. LI, Z.M. LEI, and C.V. RAO (1996) J. Clin. Endocrinol. Metab., 81, 1283-1288
24. 24. WU, R. SANDUJA, A.L. TSAI, B. FERHANOGLU and D.S. LOOSEMITCHELL (1991). Proc. Natl. Acad. Sci., 88, 2384-2387
25. 25. M. ZICHE, J. JONES and P.M. GULLINO (1982) J. Natl. Cancer Instit., 69, 475-482
26. 26. M. ESSIG, J.C. DUSSAULE, S. VANDERMEERSCH, C. CHATZIATANTONIOU and R. ARDAILLOU (1997), 75, 303-309
27. 27. T. HLA and T. MACIAG (1991) J. Biol. Chem., 266, 24059-24063
28. 28. S.M. DATHLEFSEN, D. SHEPRO and P.A. DAMORE (1994) Expt. Cell Res., 212, 262-273
29. 29. P.W. HEWETT and J.C. MURRARY (1996) Biochem. Biophys. Res. Commun., 221, 697-702
30. 30. G.H. FONG, J. ROSSANT, M. GERTSTEIN and M.L. BRIETMAN (1995) Nature, 376, 66-70